hotspot -WSS

hotspot

author：hotspot 2025-09-30 17:02:36 - browse：91748

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

Fresh off of the news that its drug Wegovy may not just help people lose weight, but could also lower cardiac risks, Novo Nordisk doubled down on its obesity drug pipeline Thursday, acquiring a small Canadian biotech with a new approach to weight loss.

Novo will spend up to $1 billion to buy Inversago Pharma, which is developing an oral obesity drug that targets the cannabinoid receptor CB1. It’s the second big obesity acquisition this year, following Eli Lilly’s move to purchase startup Versanis Bio.

Drugs like Wegovy are in a class called GLP-1 drugs, which mimic the effects of the glucagon-like peptide 1 hormone that help people feel full by targeting the hormone’s receptors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Ukraine and a new approach to mental health in war

WSS

Senate HELP committee spars over health care workforce policies

Ukraine and a new approach to mental health in war

It's been 20 years since Dolly the sheep. Where's my clone?

Venture capitalist Bob Kocher on the state of digital health

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Cytokinetics CEO stresses company can launch heart drug on its own

entertainment

hotspot

leisure time

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Data integrity in scientific journals requires "effort" by publishers, institutions

New air purifier tech could be key to improving indoor air quality

Senators: Long

Guidelines to prevent youth baseball injuries need more muscle

STAT Virtual Event: Putting AI to the Test

FDA approval of Sarepta Duchenne genetic therapy gives me hope

CDC's new outbreak response network to include Northeastern

Affirmative action in medical school literally saved lives

STAT Virtual Event: Putting AI to the Test

explore

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

How Vertex's cystic fibrosis drug is changing patients' lives

Case highlights the risks of experimental stem cell therapy

Senate HELP committee spars over health care workforce policies

Data integrity in scientific journals requires "effort" by publishers, institutions

CDC's new outbreak response network to include Northeastern

focus

hotspot

focus

knowledge